A review on newly approved PARP inhibitors: Talazoparib and Olaparib

A review on newly approved PARP inhibitors: Talazoparib and Olaparib

This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Bibliografiset tiedot
Päätekijä:	Karim, Azrin
Muut tekijät:	Islam, Farzana
Aineistotyyppi:	Project report
Kieli:	English
Julkaistu:	Brac University 2024
Aiheet:	PARP inhibitors Olaparib Talazoparib DNA damage repair DDR signaling pathway Homologous recombination repair Prostate cancer Ovarian cancer Metastatic breast cancer BRCA mutations Cancer > Treatment > Genetic aspects. DNA repair. NAD-ADP-ribosyltransferase > Inhibitors > Therapeutic use. Antineoplastic agents.
Linkit:	http://hdl.handle.net/10361/24372

Samankaltaisia teoksia

A review on potential of PARP inhibitors in the treatment of prostate cancer
Tekijä: Islam, Saidul
Julkaistu: (2022)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
Tekijä: Ahmed, Nafisa
Julkaistu: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Tekijä: Meem, Manila
Julkaistu: (2023)

Mutation in DNA polymerase γ: mitochondrial disorders
Tekijä: Hossain, Sadman Sanjid
Julkaistu: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Tekijä: Alam, Tahera
Julkaistu: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024)

Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022)

Statistics and informatics in molecular cancer research

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
Tekijä: Parvin, Salma, et al.
Julkaistu: (2016)

Association of MTHFR rs1801133, PEMT rs4244593, CHKA rs7928739, VNTRs IL-1RN intron 2 and NOS3 intron 4 polymorphisms with unexplained intrauterine fetal death in Bangladeshi population
Tekijä: Mahasin, Deera, et al.
Julkaistu: (2024)

Repairing & maintaining yard equipment & power tools /
Tekijä: Schultz, Mort J.
Julkaistu: (1994)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Tekijä: Mirza, Maisa Tasnim
Julkaistu: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Tekijä: Ratu, Tabassum
Julkaistu: (2024)

Cancer risk factors: a critical review
Tekijä: Tabassum, Tahsina
Julkaistu: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Tekijä: Nawar, Anika
Julkaistu: (2019)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
Tekijä: Mondal, Shawon
Julkaistu: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Tekijä: Khan, Muidul Hasan
Julkaistu: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Tekijä: Abir, Shifaty Nur
Julkaistu: (2024)

Targeting BRAFV600E in the treatment of CRC
Tekijä: Roja, Mashwiyat Samrin
Julkaistu: (2024)

Role of statins as antagonists of SPARC in gastric cancer
Tekijä: Shahmat, Rad
Julkaistu: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Tekijä: Pial, Sazia Afrin
Julkaistu: (2018)

A review on the role of histone deacetylase SIRT6 in high-grade serous ovarian Cancer
Tekijä: Rahman, Tazin
Julkaistu: (2022)

Epigenetic therapy in cancer
Tekijä: Abid, Md. Shadman Ridwan
Julkaistu: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Tekijä: Khondokar, Faiza
Julkaistu: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Tekijä: Rahman, Sanjida
Julkaistu: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
Tekijä: Emon, Kamrul Hasan
Julkaistu: (2022)

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Current perspectives on cancer prevention strategies: implications for Bangladesh
Tekijä: Afrin, Sajia
Julkaistu: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Tekijä: Hossain, Safa Binte
Julkaistu: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
Tekijä: Islam, Karima
Julkaistu: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
Tekijä: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
Tekijä: Yasmin, Rizwana
Julkaistu: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Tekijä: Sorno, Rubina Haque
Julkaistu: (2024)

Radar for technicians : installation, maintenance, and repair /
Tekijä: Gould, Frederick L.
Julkaistu: (1995)

Breast cancer awareness seminars
Tekijä: Anwer Khan Modern Medical College
Julkaistu: (2016)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Tekijä: Jeba, Joynob
Julkaistu: (2017)

Current scenario of Cancer in Dhaka City, Bangladesh
Tekijä: Natth, Bratakatha
Julkaistu: (2016)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Tekijä: Pecorino, Lauren
Julkaistu: (2012)